CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
-
Pick The Right PV Technology With Help From A Safety Data Management Expert
Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.
ECOA RESOURCES
-
If you're ready to streamline your clinical trials and deliver better outcomes for all stakeholders, explore how the Suvoda Platform can transform your trial experience today.
-
Experience seamless, secure, and flexible eCOA data collection with our application designed for diverse users, compatible with multiple devices, and equipped with offline functionality and robust authentication.
-
Choosing the right vendor, solution, and deployment model is critical for a clinical trial to be successful. As a sponsor, consider these seven best practices when selecting the best eCOA.
ECONSENT RESOURCES
-
Learn how informed consent — providing a potential participant with enough information about a study to allow for an informed decision about their participation — is a critical step for enrolling patients in clinical trials.
-
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
EPRO RESOURCES
-
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
-
In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.